Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Background:

• Congenital Chuvash polycythemia (CP) is characterized by VHL(R200W) homozygosity, leading to elevated hypoxia-inducible factor (HIF) levels.
• Phlebotomy, a common CP treatment, induces iron deficiency, creating a unique model to study HIF signaling and iron deficiency interplay.

Purpose of the Study:

• To investigate the distinct and combined effects of iron deficiency and HIF signaling on gene expression in CP.
• To elucidate the molecular mechanisms underlying CP phenotypes such as altered metabolism and reduced oncogenic potential.

Main Methods:

• Comparative gene expression profiling of peripheral blood mononuclear cells (PBMCs) from CP patients (VHL(R200W) homozygotes) and healthy controls.
• Analysis of gene expression data considering both normal iron status and iron deficiency (low ferritin) in CP patients.

Main Results:

• Significant differential gene expression observed in CP patients, with 812 genes up-regulated and 2120 down-regulated (FDR < 0.05).
• Identified key gene regulation modules related to innate immunity, carbohydrate/lipid metabolism, cell proliferation, apoptosis, and T-cell activation.
• Iron deficiency differentially modulated VHL(R200W) effects: enhancing 50 genes (e.g., hemoglobin synthesis) and suppressing 107 genes (HIF-2 targets), suggesting complex regulation of HIF-1α and HIF-2α.

Conclusions:

• HIF signaling and iron deficiency synergistically impact gene expression in CP, influencing fundamental cellular processes.
• Findings provide molecular insights into CP's clinical features, including altered blood sugar and low cancer risk.
• Iron deficiency plays a critical role in modulating HIF pathway activity, with distinct effects on HIF-1α and HIF-2α stability and translation.